# Trade Mark Journal No.2026/016 17 April 2026

## WO0000001911250 (10,42)

Office of origin: United States of America

Date of International Registration:2 January 2026
Date of designation in the UK: 2 January 2026

International priority date claimed: 7 July 2025 (United States of America) (99271037)

Class 10
  Saliva collection devices for medical purposes; genetic testing apparatus for medical purposes.
Class 42
  Software as a service (SaaS) services featuring software using artificial intelligence (AI) for medical purposes; software as a service (SaaS) services featuring software using artificial intelligence (AI) for managing electronic health records, scheduling and coordinating patient appointments, analyzing test results, responding to patient medical queries, interpreting patient medical history, genetic test results, and electronic health records, and predicting patient outcomes based on historical medical data for medical purposes; providing on-line non-downloadable software that enables users to analyze patient medical history, patient records, patient data, and medical information via a website; providing temporary use of online non-downloadable chatbot software using artificial intelligence (AI) for managing electronic health records, scheduling and coordinating patient appointments, analyzing test results, responding to patient medical queries, interpreting patient medical history, genetic test results, and electronic health records, and predicting patient outcomes based on historical medical data for medical purposes; providing temporary use of online non-downloadable chatbot software using artificial intelligence (AI) for medical purposes.

Bioscope.AI, Inc.

Representative: Louis T. Perry Faegre Drinker Biddle & Reath LLP, 300 N. Meridian Street,, Suite 2500, Indianapolis IN 46204, UNITED STATES OF AMERICA